Home
Live Updates
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection Against Viral Pathogens : comparemela.com
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection Against Viral Pathogens
/PRNewswire/ -- Voltron Therapeutics, a Lucius Partners portfolio company, presented new evidence that demonstrates its VaxCelerate Vaccine platform's...
Related Keywords
Orlando ,
Florida ,
United States ,
Massachusetts ,
Delaware ,
Patrick Gallagher ,
Voltron Vaxcelerate ,
Mark Poznansky ,
James Ahern ,
Immunotherapy Center ,
Exchange Commission ,
Lucius Partners ,
Immunotherapy Center At Massachusetts ,
Presentation At Military Health System Research Symposium ,
Voltron Therapeutics Inc ,
Department Of Defense Do ,
Health System Research Symposium ,
Papilloma Virus ,
Military Health System Research Symposium ,
Voltron Therapeutics ,
Vaxcelerate Vaccine ,
Massachusetts General ,
Lassa Fever ,
Novel Self Assembling Vaccine ,
Inhibits Tumor Growth ,
Tumor Model ,
Neck Cancer ,
Massachusetts General Hospital ,
Voltron Therapeutic ,
Self Assembling Vaccine ,
Emerging Infectious ,
Private Securities Litigation Reform Act ,
Vaxcelerate Platform ,
comparemela.com © 2020. All Rights Reserved.